Topical Gel Application and Low Level Laser Therapy on
Related Soft Tissue Traumatic Aphthous Ulcers
Keywords:
surgical,
fiber,
Time:25-03-2016
Traumatic aphthous ulcers (epithelial laceration that usually exposes nerve ending terminals and
result in acute and severe pain) [1], are shown on a high percentage on either children or
adults during orthodontic treatment [2,3].
Low level laser therapy (LLLT), it´s an international accepted designation defined as
laser treatment, in which the outer energy is applied at a low intensity to produce on the
tissues non thermal and bio stimulating effects [4]. LLLT has shown to have an increase in
proliferation at the cellular level due to several mechanisms [5-20]. Anti-inflammatory
properties are based on its decreasing effect on E2 prostaglandin, factor-alpha tumor necrosis,
interleukin-1β, cyclooxygenase- 2mRNA and plasmin activator levels [21]. Analgesic
properties are associated with its antiinflammatory action and neuronal effect [22-24]. Summing
all of the above, LLLT offers a potential solution and has been used in aphthous recurring
stomatitis [25-28]. Fitoestimuline Gel® it´s an oral cavity application gel, each 100
g contain aqueous Triticum vulgare extract, 15 g, 2 fenoxietanol 1 g and carbopolcarbé
Viano and Santiano [29]. searching for its action mechanism Fitostimuline® was applied over
fibroblast and lymphocytes mouse cultures, finding an increase on ARNm and DNA synthesis. The
authors concluded that this activity is the base for the action mechanism of the substances that
are a part of it, achieving the proper stimulation for tissue regeneration. This study’s
objective is to evaluate the effect of LLLT and Fitostimuline Gel® application on pain and
healing of orthodontic related traumatic aphthous lesions..
This is a clinical intervention study design, double blind and randomized clinical trial. The
initial sample was 350 suitable patients under orthodontic treatment, starting in August 2013
and finishing in May 2014, at the Universidad del Valle (Cali, Colombia) clinics and in a
private practice.
Within the appointment in which the patient reported the aphthous lesion G3 and G4 were
irradiated with Photon Lase III (AS-GA-Ir) (DMC equipments; Sao Carlos, Brazil) therapeutic
laser, with a wavelength of 660 nm, 25 J/cm2, 100 mW, during 14 seconds. Irradiation was made by
one operator, applying laser by scanning the lesion 1 mm away two times each of seven seconds.
Only one laser application per aphthous lesion was made. G1 and G2 received a placebo
application with the laser tip inactive, this in order to create a placebo effect aplication to
prevent false effects and mainly to keep the registration process in the visual analog scale as
true as possible.